A study to evaluate the cardiac and metabolic effects of MK0767 in patients with Type 2 Diabetes. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants)...
Date First Received: October 5, 2007
Last Updated: October 11, 2007
Verified by: Merck, October 2007
Clinical Trial Phase: Phase 3 | Start Date: November 2002
Overall Status: Completed
Brief Summary
Condition Keyword(s):
Intervention(s):
A study to evaluate the cardiac and metabolic effects of MK0767 in patients with Type 2 Diabetes.
This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Intervention(s) in this Clinical Trial
- Drug: MK0767
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- You are taking at least one medication for high blood sugar
- Age 21 to 80
Exclusion Criteria:
- History of Type 1 Diabetes Mellitus
- Currently on estrogen replacement therapy regimen
- Currently on a weight loss program with ongoing weight loss or taking medications for weight loss
- Having surgery 30 days before starting the study
- Have taken any other investigational drug in the past 90 days
- Have Hepatitis B or C
- Active liver or gallbladder disease
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 21 Years
Maximum Age for this Clinical Trial: 80 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Merck
Overall Clinical Trial Officials and Contacts
Medical Monitor Study Director Merck
Additional Information
Information obtained from ClinicalTrials.gov on September 05, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00543010
Study ID Number: 2007_644
ClinicalTrials.gov Identifier: NCT00543010
Health Authority: United States: Food and Drug Administration
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
